464 related articles for article (PubMed ID: 24600203)
1. Update on the use of systemic biologic agents in the treatment of noninfectious uveitis.
Pasadhika S; Rosenbaum JT
Biologics; 2014; 8():67-81. PubMed ID: 24600203
[TBL] [Abstract][Full Text] [Related]
2. Non-anti TNFα biologic agents for noninfectious uveitis associated with systemic inflammatory diseases: a systematic review.
Bitossi A; Mattioli I; Bettiol A; Palermo A; Malandrino D; Bacherini D; Virgili G; Giansanti F; Vannozzi L; Silvestri E
Expert Rev Clin Immunol; 2023 May; 19(5):549-560. PubMed ID: 36939549
[TBL] [Abstract][Full Text] [Related]
3. Current and future treatments for Behçet's uveitis: road to remission.
Mesquida M; Molins B; Llorenç V; Hernández MV; Espinosa G; Dick AD; Adán A
Int Ophthalmol; 2014 Apr; 34(2):365-81. PubMed ID: 23729309
[TBL] [Abstract][Full Text] [Related]
4. Rise of biologics in noninfectious uveitis: a retrospective cohort study from Nepal.
Sharma S; Kharel R; Parajuli S; Jha S
Ann Med Surg (Lond); 2023 May; 85(5):1486-1489. PubMed ID: 37229040
[TBL] [Abstract][Full Text] [Related]
5. Alternative Biologic Therapy in Children Failing Conventional TNFα Inhibitors for Refractory, Noninfectious, Chronic Anterior Uveitis.
Miraldi Utz V; Angeles-Han ST; Mwase N; Cassedy A; Hennard T; Lovell DJ; Lopper S; Brunner HI; Dosunmu EO; Grom AA; Henrickson M; Huggins JL; Sisk RA; Ting TV; Kaufman AH
Am J Ophthalmol; 2022 Dec; 244():183-195. PubMed ID: 35863492
[TBL] [Abstract][Full Text] [Related]
6. The use of biologic agents in the management of uveitis.
Trivedi A; Katelaris C
Intern Med J; 2019 Nov; 49(11):1352-1363. PubMed ID: 30582273
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced Sarcoid Uveitis with Biologics.
Sobolewska B; Baglivo E; Edwards AO; Kramer M; Miserocchi E; Palestine AG; Schwab IR; Zamir E; Doycheva D; Zierhut M
Ocul Immunol Inflamm; 2022 May; 30(4):907-914. PubMed ID: 33596386
[TBL] [Abstract][Full Text] [Related]
8. Noninfectious immune-mediated uveitis and ocular inflammation.
Pan J; Kapur M; McCallum R
Curr Allergy Asthma Rep; 2014 Jan; 14(1):409. PubMed ID: 24338488
[TBL] [Abstract][Full Text] [Related]
9. An Update on Treatment of Pediatric Chronic Non-Infectious Uveitis.
Sood AB; Angeles-Han ST
Curr Treatm Opt Rheumatol; 2017 Mar; 3(1):1-16. PubMed ID: 28944162
[TBL] [Abstract][Full Text] [Related]
10. Profile of adalimumab and its potential in the treatment of uveitis.
Balevic SJ; Rabinovich CE
Drug Des Devel Ther; 2016; 10():2997-3003. PubMed ID: 27698552
[TBL] [Abstract][Full Text] [Related]
11. The effect of biologic therapy different from infliximab or adalimumab in patients with refractory uveitis due to Behçet's disease: results of a multicentre open-label study.
Santos-Gómez M; Calvo-Río V; Blanco R; Beltrán E; Mesquida M; Adán A; Cordero-Coma M; García-Aparicio ÁM; Valls Pascual E; Martínez-Costa L; Hernández MV; Hernandez Garfella M; González-Vela MC; Pina T; Palmou-Fontana N; Loricera J; Hernández JL; González-Gay MA
Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S34-S40. PubMed ID: 27054359
[TBL] [Abstract][Full Text] [Related]
12. Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.
Riancho-Zarrabeitia L; Calvo-Río V; Blanco R; Mesquida M; Adan AM; Herreras JM; Aparicio Á; Peiteado-Lopez D; Cordero-Coma M; García Serrano JL; Ortego-Centeno N; Maíz O; Blanco A; Sánchez-Bursón J; González-Suárez S; Fonollosa A; Santos-Gómez M; González-Vela C; Loricera J; Pina T; González-Gay MA
Semin Arthritis Rheum; 2015 Dec; 45(3):361-8. PubMed ID: 26092330
[TBL] [Abstract][Full Text] [Related]
13. Juvenile Idiopathic Arthritis.
Barut K; Adrovic A; Şahin S; Kasapçopur Ö
Balkan Med J; 2017 Apr; 34(2):90-101. PubMed ID: 28418334
[TBL] [Abstract][Full Text] [Related]
14. Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.
Thomas AS
Curr Opin Ophthalmol; 2019 May; 30(3):138-150. PubMed ID: 30844945
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet's syndrome.
Silvestri E; Bitossi A; Bettiol A; Emmi G; Urban ML; Mattioli I; Di Scala G; Bacherini D; Lopalco G; Venerito V; Iannone F; Vitale A; Tosi GM; Rizzo S; Fabiani C; Cantarini L; Virgili G; Vannozzi L; Prisco D
Inflammopharmacology; 2020 Jun; 28(3):711-718. PubMed ID: 32157555
[TBL] [Abstract][Full Text] [Related]
16. Update on biologic therapies for juvenile idiopathic arthritis-associated uveitis.
Thomas J; Kuthyar S; Shantha JG; Angeles-Han ST; Yeh S
Ann Eye Sci; 2021 Jun; 6():. PubMed ID: 34131629
[TBL] [Abstract][Full Text] [Related]
17. The use of biologic therapies in uveitis.
Duica I; Voinea LM; Mitulescu C; Istrate S; Coman IC; Ciuluvica R
Rom J Ophthalmol; 2018; 62(2):105-113. PubMed ID: 30206553
[TBL] [Abstract][Full Text] [Related]
18. The Use of Biologic Therapies in Uveitis.
Schwartzman S; Schwartzman M
Clin Rev Allergy Immunol; 2015 Dec; 49(3):307-16. PubMed ID: 25431348
[TBL] [Abstract][Full Text] [Related]
19. Retrospective case review of pediatric patients with uveitis treated with infliximab.
Rajaraman RT; Kimura Y; Li S; Haines K; Chu DS
Ophthalmology; 2006 Feb; 113(2):308-14. PubMed ID: 16406545
[TBL] [Abstract][Full Text] [Related]
20. Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: multicentre retrospective study.
Atienza-Mateo B; Calvo-Río V; Beltrán E; Martínez-Costa L; Valls-Pascual E; Hernández-Garfella M; Atanes A; Cordero-Coma M; Miquel Nolla J; Carrasco-Cubero C; Loricera J; González-Vela MC; Vegas-Revenga N; Fernández-Díaz C; Demetrio-Pablo R; Domínguez-Casas LC; Luis Martín-Varillas J; Palmou-Fontana N; Hernández JL; González-Gay MÁ; Blanco R
Rheumatology (Oxford); 2018 May; 57(5):856-864. PubMed ID: 29471416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
